GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.
GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.
复制标题
DOI:
10.1186/s12885-022-09986-3
复制
发表时间:
2022-08-12
期刊:
影响因子:
3.8
通讯作者:
中科院分区:
文献类型:
--
作者:
Glutathione Peroxidase 4 (GPX4) is a key protein that inhibits ferroptosis. However, its biological regulation and mechanism in endometrial cancer (EC) have not been reported in detail. The expression of GPX4 in EC tissues was determined by TCGA databases, qRT-PCR, Western blot, and immunohistochemistry (IHC). The effects of GPX4 on EC cell proliferation, migration, apoptosis, and tumorigenesis were studied in vivo and in vitro. In addition, ETS Transcription Factor ELK1 (ELK1) was identified by bioinformatics methods, dual-luciferase reporter assay, and chromatin immunoprecipitation (ChIP). Pearson correlation analysis was used to evaluate the association between ELK1 and GPX4 expression. The expression of GPX4 was significantly up-regulated in EC tissues and cell lines. Silencing GPX4 significantly inhibited the proliferation, migration ability, induced apoptosis, and arrested the cell cycle of Ishikawa and KLE cells. Knockdown of GPX4 accumulated intracellular ferrous iron and ROS, disrupted MMP, and increased MDA levels. The xenograft tumor model also showed that GPX4 knockdown markedly reduced tumor growth in mice. Mechanically, ELK1 could bind to the promoter of GPX4 to promote its transcription. In addition, the expression of ELK1 in EC was positively correlated with GPX4. Rescue experiments confirmed that GPX4 knockdown could reverse the strengthens of cell proliferation and migration ability and the lower level of Fe2+ and MDA caused by upregulating ELK1. The results of the present study suggest that ELK1 / GPX4 axis plays an important role in the progress of EC by promoting the malignant biological behavior and inducing ferroptosis of EC cells, which provides evidence for investigating the potential therapeutic strategies of endometrial cancer. The online version contains supplementary material available at 10.1186/s12885-022-09986-3.
登录
查看更多内容
影响因子:
64.5
作者:
Dixon SJ;Lemberg KM;Lamprecht MR;Skouta R;Zaitsev EM;Gleason CE;Patel DN;Bauer AJ;Cantley AM;Yang WS;Morrison B 3rd;Stockwell BR
通讯作者:
Stockwell BR
影响因子:
5.2
作者:
López-Janeiro Á;Ruz-Caracuel I;Ramón-Patino JL;De Los Ríos V;Villalba Esparza M;Berjón A;Yébenes L;Hernández A;Masetto I;Kadioglu E;Goubert V;Heredia-Soto V;Barderas R;Casal JI;de Andrea CE;Redondo A;Mendiola M;Peláez-García A;Hardisson D
通讯作者:
Hardisson D
DOI:
10.18632/aging.203172
发表时间:
2021-06-21
期刊:
Aging
影响因子:
--
作者:
Chen W;Fu J;Chen Y;Li Y;Ning L;Huang D;Yan S;Zhang Q
通讯作者:
Zhang Q
影响因子:
5
作者:
通讯作者:
--
影响因子:
5.7
作者:
Ma J;Liu X;Chen H;Abbas MK;Yang L;Sun H;Sun T;Wu B;Yang S;Zhou D
通讯作者:
Zhou D